Free Trial

Fortrea Q1 2024 Earnings Report

Fortrea logo
$23.41 +1.83 (+8.48%)
(As of 01:21 PM ET)

Fortrea EPS Results

Actual EPS
-$0.04
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

Fortrea Revenue Results

Actual Revenue
$662.10 million
Expected Revenue
$754.58 million
Beat/Miss
Missed by -$92.48 million
YoY Revenue Growth
-4.60%

Fortrea Announcement Details

Quarter
Q1 2024
Time
Before Market Opens
Elon Musk’s chilling warning for humanity (Ad)

The 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern border is a travesty, but the 'invasion' I've found will have 10 times greater effects on our economy, and ultimately our way of life.

Go here to see why.

Fortrea Earnings Headlines

Fortrea: Some Green Shoots After A Dismal Period
Brokerages Set Fortrea Holdings Inc. (NASDAQ:FTRE) PT at $24.50
WARNING: “Buffett Indicator” flashing for first time in 50 years
Warren Buffett has sold a staggering $97 billion worth of stocks this year... But why? Our research indicates the Oracle of Omaha is quietly preparing for a historic market crash. His most reliable crash indicator - the "Buffett indicator" - just flashed red for the first time in 25 years.
Fortrea to Present at the Evercore HealthCONx Conference
See More Fortrea Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Fortrea? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Fortrea and other key companies, straight to your email.

About Fortrea

Fortrea Holdings Inc., a contract research organization, primarily engages in the provision of biopharmaceutical product and medical device development services worldwide. The company operates through two segments: Clinical Services and Enabling Services. The Clinical Services segment provides across the clinical pharmacology and clinical development spectrum. The Enabling Services segment provides patient access and clinical trial technology solutions to customers that streamline complex randomization and optimize the trial drug supply process. The company offers delivery models that include full service, functional service provider, and hybrid service structures. It also offers phase I-IV clinical trial management, differentiated technology enabled trial solutions, and post approval services, as well as consulting services. The company serves pharmaceutical, biotechnology, and medical device organizations. Fortrea Holdings Inc. was incorporated in 2023 and is headquartered in Durham, North Carolina.

View Fortrea Profile

More Earnings Resources from MarketBeat